drugset / Trial / NCT00563017

Evaluation of Efficacy and Safety of Long-acting Risperidone Microspheres in Patients With Schizophrenia or Other Psychotic Disorders When Switching From Typical Antipsychotic (Oral/Depot) or Atypical Oral Other Than Risperidone

NCT00563017

Non-randomizedTreatment

Summary

The purpose of this study is to evaluate the efficacy, tolerability and safety of patients on long-acting Risperidone microshpheres injection. The major advantage of long-acting injection over oral medication is facilitation of compliance in medication taking. Non-compliance is very common among schizophrenic and is a frequent cause of relapse.

Timeline

Start
2004-10
Primary completion
Completion
2005-11

Drugs

EvaluationDrugModalityDoseRoute
Subject Risperidone Other / unclassified